Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Revenue came in at $10.7 million in Q1 2026, up 2873.41% year-on-year from $361000.0 in Q1 2025, and up 74.22% quarter-over-quarter from $6.2 million in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- On a quarterly basis, Revenue rose 2873.41% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $18.1 million, a 2277.5% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 640.71% from the prior year.
- Revenue grew to $10.7 million in Q1 2026 per CRNX's latest filing, from $6.2 million in the prior quarter.
- Across five years, Revenue topped out at $10.7 million in Q1 2026 and bottomed at $143000.0 in Q3 2025.
- The 5-year median for Revenue is $674500.0 (2022), against an average of $2.0 million.
- Across the five-year window, Revenue slumped 76.11% in 2024 and soared 2873.41% in 2026, its largest moves.
- Year by year, Revenue stood at $709000.0 in 2022, then tumbled by 51.2% to $346000.0 in 2023, then grew by 15.32% to $399000.0 in 2024, then soared by 1444.11% to $6.2 million in 2025, then jumped by 74.22% to $10.7 million in 2026.
- Per Business Quant, the three latest CRNX Revenue figures stand at $10.7 million (Q1 2026), $6.2 million (Q4 2025), and $143000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 8.72 Bn | 10.53 Mn | 10.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | 6.16 Mn |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 361,000.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | 640,000.00 |
| Sep 30, 2023 | 346,000.00 |
| Jun 30, 2023 | 988,000.00 |
| Mar 31, 2023 | 2.68 Mn |
| Dec 31, 2022 | 709,000.00 |
| Sep 30, 2022 | 458,000.00 |
| Jun 30, 2022 | 439,000.00 |
| Mar 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | -71,000.00 |
| Mar 31, 2020 | 71,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Sep 30, 2019 | 505,000.00 |
| Mar 31, 2019 | 367,000.00 |